Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactobacillus LB in IBS-D
NCT04053790Phase 4Completed
- Sponsor
- Hospital General de México "Dr. Eduardo Liceaga"
- Start
- Jan 2019
- Primary completion
- Jan 2023
- Modality
- Yeast Strains, Defined Consortia, Bacterial Strains
- Countries
- 1
01
Overview
A Phase 4 trial of Lactobacillus LB in Irritable bowel syndrome with diarrhea (IBS-D), sponsored by Hospital General de México "Dr. Eduardo Liceaga". Started Jan 2019; status: completed.
02
Drugs
Lactobacillus LB
03
Conditions
Irritable bowel syndrome with diarrhea (IBS-D)
Beyond the preview
Go deeper on NCT04053790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04053790.